Search

everythinglearnresearchcommunity

for

Search:↓

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Certain gene variations are linked to alopecia areata.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Punica granatum leaf extract may help treat skin fibrosis by reducing inflammation and oxidative stress.

Bimekizumab effectively treated a man's chronic beard hair loss.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Minoxidil rejuvenates hair follicles and reduces aging signs in male pattern baldness.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Minoxidil helps hair regrowth and has anti-aging effects on hair follicles.

Hair follicles are crucial for maintaining skin barrier function.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Higher Interleukin 17A levels may indicate more severe alopecia areata.

The document concludes that a new method has been developed to test anti-aging substances on human skin, showing that these substances can reduce skin aging signs.

Cholecystokinin may help reduce skin inflammation in psoriasis.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Future acne treatments should aggressively target inflammation to prevent scarring.

PCOS causes inflammation regardless of body weight.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

A lotion with minoxidil, hydrocortisone butyrate, and 17a-estradiol can improve or stabilize Frontal Fibrosing Alopecia in some cases, but there's no universally-accepted treatment yet.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.